Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.

Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert GW, Nestel PJ, Karapanagiotidis S, Wong C, Richards K, Marusic P, Dixon JB, Schlaich MP, Lambert EA.

J Clin Endocrinol Metab. 2014 Sep;99(9):E1701-7. doi: 10.1210/jc.2014-1976. Epub 2014 Jun 17.

PMID:
24937541
2.

Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.

Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert GW, Nestel PJ, Richards K, Dixon JB, Schlaich MP, Lambert EA.

Metabolism. 2015 Jul;64(7):797-803. doi: 10.1016/j.metabol.2015.03.006. Epub 2015 Mar 18.

PMID:
25827058
3.

The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia.

Straznicky NE, Lambert EA, Grima MT, Eikelis N, Richards K, Nestel PJ, Dawood T, Masuo K, Sari CI, Dixon JB, Esler MD, Paul E, Schlaich MP, Lambert GW.

Obesity (Silver Spring). 2014 Mar;22(3):652-62. doi: 10.1002/oby.20614. Epub 2013 Dec 6.

4.

The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.

Straznicky NE, Grima MT, Sari CI, Karapanagiotidis S, Wong C, Eikelis N, Richards KL, Lee G, Nestel PJ, Dixon JB, Lambert GW, Schlaich MP, Lambert EA.

J Clin Endocrinol Metab. 2013 Feb;98(2):E227-37. doi: 10.1210/jc.2012-3277. Epub 2012 Dec 27.

PMID:
23271752
5.

Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.

Straznicky NE, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ, McGrane MT, Mariani JA, Socratous F, Chopra R, Esler MD, Schlaich MP, Lambert EA.

Am J Clin Nutr. 2009 Jan;89(1):27-36. doi: 10.3945/ajcn.2008.26299. Epub 2008 Dec 3.

6.
7.

Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.

Straznicky NE, Grima MT, Sari CI, Lambert EA, Phillips SE, Eikelis N, Kobayashi D, Hering D, Mariani JA, Dixon JB, Nestel PJ, Karapanagiotidis S, Schlaich MP, Lambert GW.

Cardiovasc Diabetol. 2015 Aug 22;14:113. doi: 10.1186/s12933-015-0276-2.

8.

Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndrome.

Straznicky NE, Grima MT, Lambert EA, Sari CI, Eikelis N, Nestel PJ, Phillips SE, Hering D, Karapanagiotidis S, Dixon JB, Schlaich MP, Lambert GW.

J Clin Endocrinol Metab. 2015 Apr;100(4):1544-50. doi: 10.1210/jc.2014-3796. Epub 2015 Jan 15.

PMID:
25590214
9.

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert EA, Nestel PJ, Esler MD, Dixon JB, Chopra R, Tilbrook AJ, Schlaich MP, Lambert GW.

Diabetes. 2012 Oct;61(10):2506-16. Epub 2012 Jun 4.

10.

Effects of insulin on vascular tone and sympathetic nervous system in NIDDM.

Tack CJ, Smits P, Willemsen JJ, Lenders JW, Thien T, Lutterman JA.

Diabetes. 1996 Jan;45(1):15-22.

PMID:
8522054
11.

Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.

Atuk NO, Hanks JB, Weltman J, Bogdonoff DL, Boyd DG, Vance ML.

J Clin Endocrinol Metab. 1994 Dec;79(6):1609-14.

PMID:
7989464
12.

Impact of insulin sensitivity treatment with pioglitazone on endothelial function in non-diabetic patients with arterial hypertension.

Schneider F, Vossler S, Franke S, Bär F, Konrad T.

Int J Clin Pharmacol Ther. 2009 May;47(5):311-20.

PMID:
19473593
13.

Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.

PMID:
15356026
14.

Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome.

Straznicky NE, Lambert GW, McGrane MT, Masuo K, Dawood T, Nestel PJ, Eikelis N, Schlaich MP, Esler MD, Socratous F, Chopra R, Lambert EA.

Diabetes. 2009 May;58(5):1126-32. doi: 10.2337/db08-1595. Epub 2009 Feb 2.

15.

Glucocorticoids, sympathetic activity, and presynaptic alpha 2-adrenoceptor function in humans.

Lenders JW, Golczynska A, Goldstein DS.

J Clin Endocrinol Metab. 1995 Jun;80(6):1804-8.

PMID:
7775627
16.

Pioglitazone improves left ventricular diastolic function in patients with essential hypertension.

Horio T, Suzuki M, Suzuki K, Takamisawa I, Hiuge A, Kamide K, Takiuchi S, Iwashima Y, Kihara S, Funahashi T, Yoshimasa Y, Kawano Y.

Am J Hypertens. 2005 Jul;18(7):949-57.

PMID:
16053992
17.

Depressor effect by exercise training is associated with amelioration of hyperinsulinemia and sympathetic overactivity.

Kohno K, Matsuoka H, Takenaka K, Miyake Y, Okuda S, Nomura G, Imaizumi T.

Intern Med. 2000 Dec;39(12):1013-9.

18.

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.

Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ.

J Clin Endocrinol Metab. 2005 Nov;90(11):5998-6005. Epub 2005 Aug 9.

PMID:
16091482
19.

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.

PMID:
16291411
20.

Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.

Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M.

Circulation. 1997 Nov 18;96(10):3423-9.

Supplemental Content

Support Center